UMDF Research Grants

The United Mitochondrial Disease Foundation (UMDF) is committed to facilitating the development of treatments and cures for mitochondrial disease and recognizes that research, from benchtop to bedside, is the path to success.

disease classes of high interest in the 2026 grant cycle:

• Disorders of mitochondrial fatty acid synthesis, including MEPAN syndrome (Mitochondrial Enoyl‑CoA Reductase Protein‑Associated Neurodegeneration)
• Disorders caused by single large‑scale mitochondrial DNA deletions (SLSMDs), including Kearns–Sayre syndrome (KSS)
• Leigh syndrome and related disorders, including Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)

Funding: $100,000 total 

Duration: 1-2 years

Research Authority due date: 19.2.26